Menu
Search
|

Menu

Close
X

GlaxoSmithKline PLC GSK.L (London Stock Exchange)

1,549.20 GBp
-8.80 (-0.56%)
As of 11:18 AM BST
chart
Previous Close 1,558.00
Open 1,561.20
Volume 1,572,469
3m Avg Volume 8,802,683
Today’s High 1,561.60
Today’s Low 1,549.20
52 Week High 1,632.00
52 Week Low 1,235.20
Shares Outstanding (mil) 4,918.63
Market Capitalization (mil) 75,181.28
Forward P/E 38.75
Dividend (Yield %) 19.00 ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.36 Mean rating from 25 analysts

KEY STATS

Revenue (mm, GBP)
FY18
7,222
FY17
30,186
FY16
27,889
FY15
23,923
EPS (GBP)
FY18
0.111
FY17
0.532
FY16
0.185
FY15
1.746
*Note: Units in Millions of British Pounds
**Note: Units in British Pounds

KEY RATIOS

Price to Earnings (TTM)
vs sector
38.75
32.76
Price to Sales (TTM)
vs sector
2.52
5.73
Price to Book (MRQ)
vs sector
92.70
5.47
Price to Cash Flow (TTM)
vs sector
17.77
23.29
Total Debt to Equity (MRQ)
vs sector
2,326.88
16.84
LT Debt to Equity (MRQ)
vs sector
1,511.59
12.51
Return on Investment (TTM)
vs sector
7.58
14.61
Return on Equity (TTM)
vs sector
278.84
16.34

EXECUTIVE LEADERSHIP

Philip Hampton
Non-Executive Chairman of the Board, Since 2015
Salary: --
Bonus: --
Emma Walmsley
Chief Executive Officer, Executive Director, Since 2017
Salary: £965,000.00
Bonus: £1,540,000.00
Simon Dingemans
Chief Financial Officer, Executive Director, Since 2011
Salary: £754,000.00
Bonus: £1,090,000.00
Roger Connor
President - Global Manufacturing & Supply, Since 2013
Salary: --
Bonus: --
Luc Debruyne
President - Global Vaccines, Since 2016
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

980 Great West Road
BRENTFORD     TW8 9GS

Phone: +4420.80475000

GlaxoSmithKline plc is a global healthcare company. The Company operates through three segments: Pharmaceuticals, Vaccines and Consumer Healthcare. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. The Company makes a range of prescription medicines, vaccines and consumer healthcare products. The Pharmaceuticals business discovers, develops and commercializes medicines to treat a range of acute and chronic diseases. The Vaccines business provides vaccines for people of all ages from babies and adolescents to adults and older people. The Consumer Healthcare business develops and markets products in Wellness, Oral health, Nutrition and Skin health categories. Its product portfolio includes Adartrel, Bexsero, Daraprim and Quinvaxem. Its brands include Panadol, abreva, polident and physiogel.

SPONSORED STORIES